Sialolithiasis

Sialolithiasis is a benign obstructive condition of the salivary glands caused by the formation of calcified concretions (sialoliths) within the ductal system or, less commonly, the gland parenchyma.[1][2] It is the most common cause of salivary gland swelling and accounts for up to 50% of all major salivary gland disease.[3] The pathogenesis is multifactorial and incompletely understood; contributing factors include salivary stasis, anatomic variability of the ductal system, salivary composition (elevated calcium and phosphate), and hyposalivation from medications, systemic disease, or smoking.[1][4] A glycoprotein nidus forms within the duct, promoting precipitation of calcium salts and progressive concentric mineralization.[3][5] The signature imaging finding is a well-defined radiopaque structure projecting over the expected course of a major salivary duct or gland, though a meaningful minority of stones are insufficiently calcified to be detected on plain radiographs.[6][7] Management is directed at relieving obstruction and preserving gland function, ranging from conservative measures to minimally invasive endoscopic and surgical approaches.[8][9]

The accepted term is sialolithiasis (the condition) and sialolith (the individual stone). Synonyms include salivary calculus, salivary stone, and salivary duct stone. The older term "salivary calculi" remains in common clinical use. Obstructive inflammation secondary to sialolithiasis is termed obstructive sialadenitis; the chronic fibrotic variant historically described in the submandibular gland is chronic sclerosing sialadenitis (Küttner tumor), which is now recognized as a distinct entity that may overlap with IgG4-related disease.[10]

• Prevalence: Lifetime prevalence is approximately 0.45–1.5% of the general population.[1][2][3]
• Age: Mean age at diagnosis ranges from 42 to 52 years; pediatric sialolithiasis is uncommon but well documented.[1][11]
• Sex: No consistent sex predilection; individual studies variably report slight male or female predominance.[1]
• Gland distribution: The submandibular gland is affected in 80–90% of cases, the parotid gland in 10–20%, and the sublingual and minor salivary glands rarely.[2][12]
• Stone location: Most submandibular stones are located in Wharton's duct (approximately 90%), whereas parotid stones are more often intraglandular. The most common ductal site is the main excretory duct, followed by the hilum.[12][13]
• Number: Solitary stones predominate (70–80% of cases); multiple stones occur in a minority.[11]

Presentation and symptoms

The hallmark presentation is recurrent, episodic, unilateral swelling and colicky pain of the affected gland, characteristically provoked by eating or salivary stimulation ("mealtime syndrome").[1][3] Symptoms may wax and wane over weeks to months, with intervening periods of remission. Rarely, sialoliths are asymptomatic and discovered incidentally on dental radiographs.[3][14]

Examination findings

• A sialolith may be palpable bimanually along the floor of the mouth (submandibular duct) or along the buccal mucosa (parotid duct).[3]
• The affected gland may be firm and tender during acute episodes.
• Saliva expressed from the duct orifice may be cloudy or absent; purulent discharge suggests superimposed acute suppurative sialadenitis.[3]

Complications

• Acute suppurative sialadenitis: Retrograde bacterial infection secondary to stasis; presents with fever, erythema, and purulent discharge.[3]
• Chronic obstructive sialadenitis: Repeated obstruction leads to progressive acinar atrophy, fibrosis, and loss of gland function.[3][15]
• Abscess formation: Rare but may require incision and drainage.
• Ductal stenosis: May develop secondary to chronic inflammation or as a postoperative sequela.[16]

Location and distribution

Sialoliths project over the anatomic course of the major salivary ducts and glands on dental radiographs. On panoramic radiographs, submandibular stones typically appear below and medial to the inferior border of the mandible, overlapping the mandibular body or angle region. Stones in the anterior portion of Wharton's duct may be visible on mandibular occlusal radiographs, projecting over the floor of the mouth. Parotid duct stones project over the ramus or buccal soft tissues, often superimposed on the mandible.[17] On cross-sectional imaging, the precise relationship to the duct versus gland parenchyma is readily determined, which is critical for surgical planning.[18][19]

Periphery and shape

Sialoliths are characteristically well-defined, smoothly contoured radiopacities. Submandibular duct stones tend to be elongated or cylindrical, conforming to the duct lumen, whereas intraglandular stones are more commonly round or ovoid.[12][13] Parotid stones are generally smaller and less densely calcified than submandibular stones.[13] Irregular or lobulated contours may be seen with larger or long-standing stones.

Internal architecture

The internal density of sialoliths varies with the degree of mineralization. Most submandibular stones are homogeneously radiopaque on conventional radiographs.[7] On cross-sectional imaging, a concentric laminated pattern of alternating organic and inorganic layers surrounding a central nidus is characteristic.[2][5] Some stones demonstrate a more heterogeneous or mixed internal pattern, particularly those arising in the parotid gland.[2] Stones with low mineral content may appear faintly radiopaque or entirely radiolucent on plain films; approximately 20% of submandibular stones and up to 40–50% of parotid stones are not visible on conventional radiographs.[6][7][20]

Size

Most sialoliths range from a few millimeters to 10–15 mm in greatest dimension. The mean size in large series is approximately 7–9 mm.[11][21] Giant sialoliths exceeding 15–20 mm are rare. Stone size is a key determinant of treatment approach: stones 7 mm typically require a combined or open surgical approach.[19][22]

Effects on adjacent structures

• Ductal dilation: Proximal duct dilation is a common secondary finding, best appreciated on cross-sectional imaging or sialography.[23]
• Gland enlargement: The affected gland may appear diffusely enlarged during acute obstruction.
• Gland atrophy: Chronic obstruction leads to progressive gland atrophy and fatty replacement, identifiable on cross-sectional imaging.[24]
• Sialoliths do not cause resorption of adjacent bone or teeth.

Sensitivity of imaging modalities

Conventional radiographs (panoramic, occlusal) detect only those stones with sufficient calcification; sensitivity is limited by superimposition of osseous structures and the variable radiopacity of stones.[6][7] CBCT offers superior sensitivity (79–94%) and specificity (90%) compared with conventional radiographs and ultrasonography, with an overall accuracy of 92% in one large cohort.[18][25] CBCT sialography further improves detection of both stones and associated ductal changes such as sialodochitis and stenosis.[23][26] CBCT is particularly valuable for localizing stones relative to the duct and gland, determining stone number, and identifying small or faintly calcified stones that are occult on panoramic radiographs.[9][18]

Recognized variants

• Multiple sialoliths: Present in a minority of cases; may be clustered or distributed along the duct.[11]
• Bilateral sialolithiasis: Uncommon; when present, cross-sectional imaging is essential to define the full extent of disease.[6]
• Minor salivary gland sialoliths: Rare; present as small submucosal calcifications, most commonly in the upper lip; approximately half are radiolucent on plain films.[20]

Ultrasonography

Ultrasonography is widely used as a first-line imaging modality for suspected sialolithiasis. Sialoliths appear as markedly hyperechoic foci with posterior acoustic shadowing.[27][28] Sensitivity ranges from 65% to 95% and specificity from 80% to 97%, with a pooled sensitivity of approximately 90% in meta-analysis.[3][29] Limitations include operator dependence, difficulty detecting stones [29][30] Ultrasonography also demonstrates secondary findings including ductal dilation proximal to the stone and gland parenchymal changes.[27]

Computed tomography

Non-contrast CT has the highest sensitivity (96–98%) and specificity (88–100%) among all imaging modalities for sialolith detection.[3][31] Stones appear as discrete hyperdense foci within the duct or gland. CT is particularly useful for detecting radiolucent stones missed on plain radiographs, delineating stone number and size, and identifying complications such as abscess.[6][31] Secondary gland changes on CT include diffuse enlargement in acute sialadenitis and atrophy with fatty replacement in chronic disease.[24]

Magnetic resonance imaging and MR sialography

MR sialography provides non-invasive visualization of the ductal system without contrast injection and is comparable to conventional sialography for detecting obstructions and strictures.[3] MRI can classify glands into active inflammation (enlarged, T2-hyperintense), chronic fatty replacement, or normal parenchyma, correlating with histopathologic stage.[24] Sialoliths appear as signal voids on all MR sequences. Combined non-contrast CT and MR sialography provides the highest combined sensitivity and specificity for preoperative planning.[31]

The primary differential consideration for sialolithiasis on dental radiographs is other calcified entities projecting over the submandibular or parotid regions. The clinical context of periprandial gland swelling is the most important discriminator; when this history is absent, alternative diagnoses should be considered carefully.

The highest-risk diagnostic pitfall is mistaking a calcification within a salivary gland malignancy for a benign sialolith, particularly in the parotid gland. When periprandial symptoms are absent, the calcification is atypical in morphology, or sialendoscopy fails to identify an intraluminal stone, further evaluation with cross-sectional imaging and tissue sampling should be pursued.[34][36]

Stone composition

Sialoliths consist of an amorphous mineralized nucleus (nidus) surrounded by concentric laminated layers of alternating organic and inorganic material.[5][12] The organic matrix includes glycoproteins, collagen, lipids, and cellular debris including exfoliated ductal epithelial cells and bacterial biofilm.[5][37] The principal inorganic constituents are hydroxyapatite, carbonate apatite, whitlockite, and octacalcium phosphate.[2][12] The calcium-to-phosphorus ratio is highest in the intermediate compact zone of the stone.[5] Submandibular stones tend to have whitlockite as the predominant crystalline phase, whereas parotid stones more commonly contain octacalcium phosphate.[13]

Gland histopathology

Chronic obstruction produces a spectrum of changes in the affected gland:

• Early: Ductal dilation, periductal inflammatory infiltrate (lymphocytes, plasma cells), and early acinar atrophy.[15]
• Progressive: Interlobular and intralobular fibrosis, acinar cell loss, ductal metaplasia (squamous and mucous cell), and intraluminal microcalcifications in striated and excretory ducts.[15][38]
• Late: Extensive parenchymal replacement by fibrous tissue and fat, with residual dilated ducts; the gland may become non-functional.[15][24]

IgG4-positive plasma cells are commonly found in the inflammatory infiltrate of sialadenitis associated with sialolithiasis, but genuine IgG4-related disease is exceedingly rare in this setting.[10]

Radiologic-pathologic correlation

MRI and CT findings of gland enlargement with active inflammation correspond histologically to acute or subacute obstructive sialadenitis with preserved but inflamed acini. Gland atrophy and fatty replacement on imaging correspond to end-stage fibrosis and acinar loss.[24]

Conservative management

Initial management for uncomplicated sialolithiasis includes hydration, salivary gland massage, sialagogues (e.g., sour candies, citric acid lozenges), warm compresses, and analgesics.[3][39] Antibiotics are indicated for superimposed acute suppurative sialadenitis.[3] Conservative measures alone may result in spontaneous stone passage for small, mobile, distally located stones.

Surgical management

The surgical approach is determined by stone size, location, number, and gland involved:[19][22]

• Sialendoscopy alone: First-line interventional approach for small stones.[3][8]
• Transoral sialolithotomy (with or without sialendoscopy): Preferred for palpable stones in the anterior or mid-duct of the submandibular gland; success rates exceed 95% for accessible stones.[21][22]
• Combined endoscopic-surgical approach: For larger (>5–7 mm), proximal, hilar, or impacted stones not amenable to endoscopic extraction alone.[22][40]
• Lithotripsy: Extracorporeal shockwave lithotripsy (ESWL) or intracorporeal laser lithotripsy may be considered for intermediate-sized stones (5–7 mm), particularly in the parotid gland; availability varies by region.[22][40]
• Gland excision (sialadenectomy): Reserved for cases with failed minimally invasive treatment, recurrent disease, or severely damaged glands with irreversible chronic sialadenitis.[8][41]

Recurrence and prognosis

Recurrence after minimally invasive surgery is uncommon, reported at approximately 5% in a large series with a mean follow-up of 20 months.[42] Recurrences almost always involve the same gland as the primary stone and tend to occur within the first few years after treatment.[16][42] Larger primary stone size may be a risk factor for recurrence.[16] Long-term symptom outcomes after sialendoscopy-assisted surgery are favorable, with complete symptom resolution in 85% of patients at one year.[43] Gland-preserving approaches have largely supplanted routine si